Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Anita M. Loughlin"'
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0216044 (2019)
BackgroundTardive dyskinesia (TD) is a movement disorder resulting from treatment with typical and atypical antipsychotics. An estimated 16-50% of patients treated with antipsychotics have TD, but this number may be underestimated. The objectives of
Externí odkaz:
https://doaj.org/article/a3c48f7672be4f7db0554eb680132f83
Autor:
M. C. Doherty, Cheryl Enger, Andrea K. Chomistek, Stacey A. Missmer, Anita M Loughlin, Gally Reznor, Stephanie E Chiuve
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:1675-1686
Background The prevalence of adenomyosis is underestimated due to lack of a specific diagnostic code and diagnostic delays given most diagnoses occur at hysterectomy. Objectives To identify women with adenomyosis using indicators derived from natural
Autor:
Linda A. Feagins, Page C. Moore, Margaux M. Crabtree, Celeste A. Lemay, Anita M. Loughlin, Jill K. Gaidos
Publikováno v:
American Journal of Gastroenterology. 117:e639-e640
Publikováno v:
Diabetes, Obesity & Metabolism
Background Although randomized, controlled trials (RCTs) are seen as the gold standard for evidence in clinical medicine, a number of considerations are increasing the use of real‐world data (RWD) to generate evidence. A series of methodological ch
Autor:
Anita M. Loughlin, Winifred Werther
Publikováno v:
Principles and Practice of Clinical Trials ISBN: 9783319526775
Principles and Practice of Clinical Trials
Principles and Practice of Clinical Trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1036ea94afe9479795892fa05c781b3
https://doi.org/10.1007/978-3-319-52677-5_256-1
https://doi.org/10.1007/978-3-319-52677-5_256-1
Autor:
Gerald J. Dal Pan, Jerry Avorn, Lee L. Zwanziger, Esther H. Zhou, Amy Ramanadham, Aaron S. Kesselheim, Cheryl Enger, Zhigang Lu, Michael S. Sinha, Brian M. Lappin, Eric G. Campbell, Frazer A. Tessema, Anita M Loughlin, Paula Rausch
Publikováno v:
The Journal of law, medicineethics : a journal of the American Society of Law, MedicineEthics. 47(3)
Drug Safety Communications (DSCs) are used by the Food and Drug Administration (FDA) to inform health care providers, patients, caregivers, and the general public about safety issues related to FDA-approved drugs. To assess patient knowledge of the m
Autor:
Anita M. Loughlin, Robert Gately, Stephen M. Ezzy, Peter Öhman, David D. Dore, C. Robin Clifford, Qing Qiao, Anthony P. Nunes, Laura Yochum, John D. Seeger
Publikováno v:
Diabetes, Obesity & Metabolism
Aim To evaluate the effectiveness and tolerability of exenatide once weekly (EQW) compared with basal insulin (BI) among injectable-drug-naive patients with type 2 diabetes mellitus (T2DM) who are elderly or have renal impairment (RI). Materials and
Autor:
John D. Seeger, C. Robin Clifford, Robert Gately, Stephen M. Ezzy, David D. Dore, Anthony P. Nunes, Laura Yochum, Qing Qiao, Anita M. Loughlin
Publikováno v:
Diabetes Therapy
Introduction Analyses of efficacy and tolerability of pharmacologic interventions are based on clinical trials that often include predominately white populations, in part because of challenges associated with recruitment and retention of racial/ethni
Autor:
Jud C. Janak, Raymond K. Cross, Page C. Moore, Philip J. Mease, Celeste A. Lemay, David Hudesman, Joshua R. Korzenik, Anita M. Loughlin, Mark Lebwohl
Publikováno v:
Gastroenterology. 160:S-543
Autor:
Robert Gately, John D. Seeger, David D. Dore, Stephen M. Ezzy, Anita M. Loughlin, Anthony P. Nunes, Laura Yochum, Qing Qiao, C. Robin Clifford
Publikováno v:
Diabetes Spectrum : A Publication of the American Diabetes Association
A propensity-matched cohort study compared injectable-naive patients with type 2 diabetes initiating exenatide once weekly (EQW) or basal insulin (BI), from 2012 through 2015, within a U.S. electronic health record database. A1C and weight were obtai